Vitamin D deficiency in patients with chronic liver disease and cirrhosis

被引：52

作者：

Lim L.Y. ^{[1
]}

Chalasani N. ^{[1
]}

机构：

[1] Division of Gastroenterology and Hepatology, Indiana University, School of Medicine, Indianapolis, IN 46202

来源：

Current Gastroenterology Reports | 2012年 / 14卷 / 1期

关键词：

Cirrhosis; Fatty liver; Hepatitis C; Vitamin D;

D O I：

10.1007/s11894-011-0231-7

中图分类号：

学科分类号：

摘要：

Vitamin D is now widely recognized to have multiple extraskeletal health functions. The liver is one of the major organs involved in its metabolism. Recent studies have demonstrated a very high prevalence of vitamin D deficiency and insufficiency in patients with chronic liver disease and cirrhosis. There is an emerging interest to explore the relationship between vitamin D deficiency and prevalence and severity of non-alcoholic liver disease and response to antiviral therapy in hepatitis C. In this review, we discuss the current status of our understanding of vitamin D metabolism and vitamin D deficiency in patients with chronic liver disease and cirrhosis. © 2011 Springer Science+Business Media, LLC.

引用

页码：67 / 73

页数：6

共 63 条

[1]

Mora J.R., Iwata M., Von Andrian U.H., Vitamin effects on the immune system: Vitamins A and D take centre stage, Nat Rev Immunol, 8, 9, pp. 685-698, (2008)

[2]

Cantorna M.T., Mahon B.D., Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence, Experimental Biology and Medicine, 229, 11, pp. 1136-1142, (2004)

[3]

Nagpal S., Na S., Rathnachalam R., Noncalcemic actions of vitamin D receptor ligands, Endocrine Reviews, 26, 5, pp. 662-687, (2005)

[4]

Timms P.M., Mannan N., Hitman G.A., Noonan K., Mills P.G., Syndercombe-Court D., Aganna E., Price C.P., Boucher B.J., Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: Mechanisms for inflammatory damage in chronic disorders?, QJM - Monthly Journal of the Association of Physicians, 95, 12, pp. 787-796, (2002)

[5]

Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., Holick M.F., Decreased bioavailability of vitamin D in obesity, American Journal of Clinical Nutrition, 72, 3, pp. 690-693, (2000)

[6]

Blum M., Dallal G.E., Dawson-Hughes B., Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older adults, J Am Coll Nutr, 27, 2, pp. 274-279, (2008)

[7]

Weisman Y., Harell A., Edelstein S., 1α,25-Dihydroxyvitamin D 3 and 24,25-dihydroxyvitamin D 3 in vitro synthesis by human decidua and placenta, Nature, 281, 5729, pp. 317-319, (1979)

[8]

Gray T.K., Lester G.E., Lorenc R.S., Evidence for extra-renal 1 α-hydroxylation of 25-hydroxyvitamin D 3 in pregnancy, Science, 204, 4399, pp. 1311-1313, (1979)

[9]

Stoffels K., Overbergh L., Bouillon R., Mathieu C., Immune regulation of 1α-hydroxylase in murine peritoneal macrophages: Unravelling the IFNγ pathway, Journal of Steroid Biochemistry and Molecular Biology, 103, 3-5, pp. 567-571, (2007)

[10]

Holick M.F., Vitamin D: A millenium perspective, Journal of Cellular Biochemistry, 88, 2, pp. 296-307, (2003)

← 1 2 3 4 5 6 7 →